SARS-CoV-2 humoral responses following booster BNT162b2 vaccination in patients with B-cell malignancies

Terpos, E; Fotiou, D; Karalis, V; Ntanasis-Stathopoulos, I; Sklirou, AD; Gavriatopoulou, M; Malandrakis, P; Iconomidou, VA; Kastritis, E; Trougakos, IP; Dimopoulos, MA

Terpos, E (通讯作者),Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens 11528, Greece.

AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (10): 1300

Abstract

Patients with B-cell malignancies have suboptimal immune responses to SARS-CoV-2 vaccination and are a high-risk population for severe COVID19 disease......

Full Text Link